BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35073615)

  • 21. Neonatal severe hyperparathyroidism: A case report.
    Shaukat M; Ahmad HM; Shafiq MU
    J Pak Med Assoc; 2022 Dec; 72(12):2538-2541. PubMed ID: 37246686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
    Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.
    Mahajan A; Buse J; Kline G
    Osteoporos Int; 2020 Jan; 31(1):203-207. PubMed ID: 31641801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet.
    Reh CM; Hendy GN; Cole DE; Jeandron DD
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E707-12. PubMed ID: 21289269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Case of Neonatal Severe Hyperparathyroidism: Challenges in Management.
    Gupta P; Tak SA; S AV; Misgar RA; Agarwala S; Jain V; Sharma R
    Indian J Pediatr; 2022 Oct; 89(10):1025-1027. PubMed ID: 35380381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites.
    Hannan FM; Nesbit MA; Zhang C; Cranston T; Curley AJ; Harding B; Fratter C; Rust N; Christie PT; Turner JJ; Lemos MC; Bowl MR; Bouillon R; Brain C; Bridges N; Burren C; Connell JM; Jung H; Marks E; McCredie D; Mughal Z; Rodda C; Tollefsen S; Brown EM; Yang JJ; Thakker RV
    Hum Mol Genet; 2012 Jun; 21(12):2768-78. PubMed ID: 22422767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual case of neonatal hypercalcemia.
    Brickman TM; Stark MW; Jeyakumar A
    Int J Pediatr Otorhinolaryngol; 2015 May; 79(5):758-9. PubMed ID: 25792032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2.
    Hannan FM; Stevenson M; Bayliss AL; Stokes VJ; Stewart M; Kooblall KG; Gorvin CM; Codner G; Teboul L; Wells S; Thakker RV
    Hum Mol Genet; 2021 May; 30(10):880-892. PubMed ID: 33729479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.
    Mastromatteo E; Lamacchia O; Campo MR; Conserva A; Baorda F; Cinque L; Guarnieri V; Scillitani A; Cignarelli M
    BMC Endocr Disord; 2014 Oct; 14():81. PubMed ID: 25292184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.
    Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss-of-Function Gα
    Gorvin CM; Hannan FM; Cranston T; Valta H; Makitie O; Schalin-Jantti C; Thakker RV
    J Bone Miner Res; 2018 Jan; 33(1):32-41. PubMed ID: 28833550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene.
    Tõke J; Czirják G; Patócs A; Enyedi B; Gergics P; Csákváry V; Enyedi P; Tóth M
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):385-92. PubMed ID: 17555508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
    Ngamkam J; Vadcharavivad S; Areepium N; Auamnoy T; Takkavatakarn K; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    Sci Rep; 2021 Sep; 11(1):18006. PubMed ID: 34504264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case Report: Unusual Presentations of Loss-of-Function Mutations of the Calcium-Sensing Receptor.
    Palmieri S; Grassi G; Guarnieri V; Chiodini I; Arosio M; Eller-Vainicher C
    Front Med (Lausanne); 2021; 8():809067. PubMed ID: 35141253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal severe hyperparathyroidism: further clinical and molecular delineation.
    Al-Khalaf FA; Ismail A; Soliman AT; Cole DE; Ben-Omran T
    Eur J Pediatr; 2011 May; 170(5):625-31. PubMed ID: 20972686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.
    Egbuna OI; Brown EM
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):129-48. PubMed ID: 18328986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal severe hyperparathyroidism secondary to a novel homozygous
    Ahmad N; Bahasan M; Al-Ghamdi BAA; Al-Enizi HF; Al-Zahrani AS
    Clin Cases Miner Bone Metab; 2017; 14(3):354-358. PubMed ID: 29354167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and clinical analysis of a neonatal severe hyperparathyroidism case caused by a stop mutation in the calcium-sensing receptor extracellular domain representing in effect a human 'knockout'.
    Ward DT; Mughal MZ; Ranieri M; Dvorak-Ewell MM; Valenti G; Riccardi D
    Eur J Endocrinol; 2013 Jul; 169(1):K1-7. PubMed ID: 23612447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rare diseases caused by abnormal calcium sensing and signalling.
    Tőke J; Czirják G; Enyedi P; Tóth M
    Endocrine; 2021 Mar; 71(3):611-617. PubMed ID: 33528764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.